Atlas Trials

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)

Clinical trial NCT00996437 · COMPLETED

Trial details

NCT number
NCT00996437
Sponsor
Jaeb Center for Health Research
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Vitreous HemorrhageProliferative Diabetic Retinopathy
Start date
2010-06-01
Primary completion
2012-02-01
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.